Thyrocare Technologies Limited (NSE:THYROCARE)
India · Delayed Price · Currency is INR 493.20
+7.90 (1.63%)
Nov 11, 2026, 1:15 PM IST
Thyrocare Technologies Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 9,303 | 8,290 | 6,874 | 5,719 | 5,267 | 5,889 |
Revenue Growth | 21.98% | 20.61% | 20.19% | 8.59% | -10.56% | 19.05% |
Gross Profit Gross Profit Growth | 5,140 | 4,477 | 3,454 | 2,755 | 2,423 | 3,469 |
Operating Income Operating Income Growth | 2,381 | 2,038 | 1,352 | 917.1 | 821.9 | 2,010 |
Net Income Net Income Growth | 1,442 | 1,630 | 915.1 | 707.6 | 644.9 | 1,761 |
Earnings Per Share EPS Growth | 8.96 | 10.21 | 5.74 | 4.45 | 4.06 | 11.08 |
EPS Growth | 11.39% | 78.08% | 28.98% | 9.65% | -63.41% | 55.59% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Diagnostic Testing Services Diagnostic Testing Services Growth | 8,756 | 7,725 | 6,297 | 5,222 | 4,812 | 5,554 |
Imaging Services Imaging Services Growth | 519.3 | 531.4 | 542.9 | 476 | 402.1 | 273.4 |
Others Others Growth | 27.9 | 33.7 | 33.7 | 20.5 | 52.4 | 61.6 |
Total Total Growth | 9,303 | 8,290 | 6,874 | 5,719 | 5,267 | 5,889 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,061 | 1,898 | 1,550 | 1,461 | 1,401 | 1,388 |
Total Debt Total Debt Growth | 568.8 | 506.9 | 246.8 | 423.4 | 233.1 | 207 |
Net Cash (Debt) Net Cash Growth | 1,493 | 1,391 | 1,304 | 1,038 | 1,168 | 1,181 |
Net Cash Growth | -11.01% | 6.73% | 25.62% | -11.13% | -1.17% | 8.19% |
Net Cash Per Share Net Cash Per Share Growth | 9.27 | 8.72 | 8.17 | 6.52 | 7.34 | 7.43 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,189 | 2,132 | 1,799 | 1,676 | 1,293 | 1,134 |
Capital Expenditures CapEx Growth | -382.9 | -208.8 | -334.8 | -615.8 | -436.5 | -378.3 |
Free Cash Flow Free Cash Flow Growth | 1,807 | 1,924 | 1,464 | 1,061 | 856.6 | 755.8 |
Free Cash Flow Growth | 2.37% | 31.37% | 38.08% | 23.80% | 13.34% | -14.15% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 55.25% | 54.00% | 50.26% | 48.17% | 46.00% | 58.92% |
Operating Margin | 25.60% | 24.58% | 19.67% | 16.04% | 15.61% | 34.14% |
Pretax Margin | 21.69% | 25.68% | 21.16% | 16.78% | 16.82% | 38.67% |
Profit Margin | 15.50% | 19.67% | 13.31% | 12.37% | 12.25% | 29.91% |
FCF Margin | 19.42% | 23.20% | 21.30% | 18.54% | 16.26% | 12.83% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 9.333 | 9.330 | 7.000 | 6.000 | 6.000 | 5.000 |
Dividend Per Share Growth | 33.33% | 33.29% | 16.67% | 0% | 20.00% | -40.00% |
Dividend Yield | 1.89% | 2.67% | 3.09% | 3.04% | 4.19% | 1.94% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 55.06 | 34.14 | 39.39 | 44.32 | 35.27 | 23.24 |
P/FCF Ratio | 43.46 | 28.94 | 24.62 | 29.57 | 26.55 | 54.16 |
PS Ratio | 8.44 | 6.72 | 5.24 | 5.48 | 4.32 | 6.95 |